Doctor profile · Federal record
Dr. Lina Husienzad, M.D.
Dermatology Physician (CMS: Dermatology) · Villanova, PA
- NPI 1417489055
- Accepts Medicare
- MIPS 94.2 / 100 · 2023
- 9 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
775 E Lancaster Ave Ste 200
Villanova, PA 190851529
(610) 525-7800
Credentials & registration
- NPI registered
- April 2017 — 9 yrs on file
- Profile last updated
- August 11, 2021
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Pennsylvania #MD473462
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1417489055. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,207
Distinct HCPCS
10
Medicare allowed
$100,459
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 323 | 54 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 234 | 182 | $95 | |
17110 |
Destruction of skin growth, 1-14 growths | 144 | 114 | $121 | |
11102 |
Biopsy of related skin growth, first growth | 113 | 109 | $93 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 108 | 94 | $134 | |
17000 |
Destruction of precancer skin growth, 1 growth | 91 | 80 | $53 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 72 | 72 | $119 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 35 | 35 | $171 | |
11103 |
Biopsy of related skin growth, each additional growth | 25 | 19 | $54 | |
12032 |
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 19 | 19 | $318 |
In context: peer comparison
Among 1 peers in Villanova Dermatology Physician, average services per provider: 92. This provider delivers 13× the peer median.Open Payments
Industry payments received
All-time total
$1,334
Transactions
67
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 11 | $220.18 | |
| Abbvie INC. | 13 | $214.17 | |
| Incyte Corporation | 9 | $171.48 | |
| Leo Pharma INC. | 9 | $145.02 | |
| Arcutis Biotherapeutics, INC. | 8 | $144.89 | |
| Amgen INC. | 4 | $96.51 | |
| Regeneron Healthcare Solutions, INC. | 2 | $68.88 | |
| Pfizer INC. | 2 | $35.21 | |
| Lilly USA, LLC | 2 | $34.44 | |
| Genzyme Corporation | 1 | $31.20 | |
| Ucb, INC. | 1 | $29.87 | |
| Sun Pharmaceutical Industries INC. | 2 | $29.09 | |
| Blueprint Medicines Corporation | 1 | $26.35 | |
| Dermavant Sciences, INC. | 1 | $24.61 | |
| Novartis Pharmaceuticals Corporation | 1 | $24.25 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
314
Patients
163
Total drug cost
$15,023
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 70 | 45 | $554 |
| Ketoconazole | Generic | 48 | 26 | $721 |
| Clobetasol Propionate | Generic | 31 | 16 | $2,158 |
| Mupirocin | Generic | 26 | 18 | $215 |
| Hydrocortisone | Generic | 23 | 16 | $193 |
| Doxycycline Hyclate | Generic | 20 | 15 | $703 |
| Clindamycin Phosphate | Generic | 16 | 0 | $992 |
| Fluorouracil | Generic | 16 | 15 | $807 |
| Cephalexin | Generic | 15 | 12 | $115 |
| Clotrimazole | Generic | 13 | 0 | $146 |
Frequently asked questions
What is Dr. Lina Husienzad's medical specialty?
Dr. Lina Husienzad practices Dermatology Physician in Villanova, PA.
Where does Dr. Lina Husienzad practice?
Dr. Lina Husienzad practices at 775 E Lancaster Ave Ste 200, Villanova, PA 190851529. Office phone: 6105257800.
What is Dr. Lina Husienzad's NPI?
Dr. Lina Husienzad's National Provider Identifier (NPI) is 1417489055, issued by NPPES.
Does Dr. Lina Husienzad accept Medicare assignment?
Yes. Dr. Lina Husienzad accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lina Husienzad commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.